Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sinopharm Group Co. Ltd. Board/Management Information 2011

Jan 20, 2011

49684_rns_2011-01-20_bb39ae85-1a4d-44dd-93f1-dbad13de63d5.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [57 x 70] intentionally omitted <==


SINOPHARM GROUP CO. LTD. 國藥控股股份有限公司

(A joint stock limited company incorporated in the People’s Republic of China with limited liability and carrying on business in Hong Kong as 國控股份有限公司 )

(Stock Code: 01099)

SUPPLEMENTAL ANNOUNCEMENT

Reference is made to the announcements of Sinopharm Group Co. Ltd. (the “ Company ”) dated 24 August 2010 and 7 January 2011 in relation to, among other matters, the appointment of Mr. Yao Fang (“ Mr. Yao ”) as a Supervisor (the “ Announcements ”). Unless the context otherwise requires, capitalized terms used herein shall bear the same meanings as those defi ned in the Announcements.

The Board further announces that Mr. Yao served as a non-executive director of Lianhua Supermarket Holdings Co., Ltd. (a company listed on the Main Board of The Stock Exchange of Hong Kong Limited) from 28 June 2007 to 27 May 2009. Save as disclosed in the Announcements and herein, there is no further information relating to Mr. Yao which is required to be disclosed pursuant to Rule 13.51(2)(h) to (v) of the Listing Rules.

By order of the Board Sinopharm Group Co. Ltd. She Lulin Chairman

Shanghai, the People’s Republic of China 20 January 2011

As at the date of this announcement, the executive director of the Company is Mr. Wei Yulin; the non-executive directors of the Company are Mr. She Lulin, Mr. Wang Qunbin, Mr. Chen Wenhao, Mr. Zhou Bin, Mr. Deng Jindong, Mr. Chen Qiyu, Mr. Fan Banghan and Mr. Liu Hailiang; and the independent non-executive directors of the Company are Mr. Wang Fanghua, Mr. Xie Rong, Mr. Tao Wuping and Mr. Zhou Bajun.

  • The Company is registered as a non-Hong Kong company under Part XI of the Companies Ordinance (Chapter 32 of the Laws of Hong Kong) under its Chinese name and the English name “Sinopharm Group Co. Ltd.”